Table 5.
Correlation of MEX3 with Pathological histology in NSCLC patients
| Pathology subtype | Case-low | Case-high | HR (95% CI) | P value | |
|---|---|---|---|---|---|
| MEX3A | All | 576 | 568 | 1.48 (1.26–1.75) | 2.9E−06 |
| LUAD | 339 | 333 | 1.74 (1.36–2.22) | 9.9E−06 | |
| LUSC | 136 | 135 | 1.00 (0.73–1.36) | 0.99 | |
| MEX3B | All | 589 | 555 | 1.37 (1.17–1.62) | 1.4E−04 |
| LUAD | 340 | 332 | 1.32 (1.04–1.68) | 0.023 | |
| LUSC | 137 | 134 | 1.05 (0.77–1.42) | 0.78 | |
| MEX3C | All | 962 | 963 | 0.81 (0.71–0.91) | 7.8E−04 |
| LUAD | 360 | 359 | 0.50 (0.39–0.63) | 5.6E−09 | |
| LUSC | 262 | 262 | 0.87 (0.69–1.11) | 0.26 | |
| MEX3D | All | 962 | 963 | 1.30 (1.14–1.47) | 5.2E−05 |
| LUAD | 361 | 358 | 2.13 (1.67–2.72) | 4.5E−10 | |
| LUSC | 262 | 262 | 0.76 (0.60–0.96) | 0.02 |
NSCLC non-small-cell lung cancer, All stands for NSCLC, LUAD lung adenocarcinoma, LUSC lung squamous cell carcinomas, HR hazard ratio, CI confidence interval, Cases-low/high patient number of low/high expression of the corresponding gene